EyePoint Pharmaceuticals ...

AI Score

0

Unlock

7.34
0.14 (1.94%)
At close: Jan 15, 2025, 12:36 PM

EyePoint Pharmaceuticals Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018
License And Collaboration Agreement Revenue 9.56M 7.78M 14.14M 3.60M 34.00K 202.00K 7.27M 7.42M 4.61M 11.19M 8.59M 4.17M 3.03M 6.68M 5.76M 3.71M 4.74M 55.00K 6.71M 543.00K 430.00K
License And Collaboration Agreement Revenue Growth +22.86% -44.95% +293.02% +10479.41% -83.17% -97.22% -1.99% +60.94% -58.78% +30.26% +106.12% +37.54% -54.66% +16.01% +55.37% -21.86% +8523.64% -99.18% +1134.81% +26.28% n/a
Product Revenue 664.00K 1.07M 816.00K 5.27M 7.39M 474.00K n/a n/a n/a 5.83M 3.93M 8.74M n/a 3.96M 3.47M 2.88M n/a n/a 6.71M n/a n/a
Product Revenue Growth -37.83% +30.88% -84.52% -28.69% +1459.92% n/a n/a n/a n/a +48.55% -55.05% n/a n/a +14.20% +20.39% n/a n/a n/a n/a n/a n/a
Royalty Revenue 299.00K 627.00K 249.00K 235.00K 255.00K 9.02M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Royalty Revenue Growth -52.31% +151.81% +5.96% -7.84% -97.17% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Y U T I Q Product Revenue 700.00K 1.10M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Y U T I Q Product Revenue Growth -36.36% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Jun 30, 2018Jun 30, 2017Jun 30, 2016Jun 30, 2015
China Revenue 823.00K 851.00K 11.71M 1.12M 2.86M 7.44M 1.52M 26.46M
China Revenue Growth -3.29% -92.73% +944.87% -60.82% -61.54% +389.41% -94.26% n/a
United States Revenue 40.48M 35.99M 22.62M 19.14M n/a n/a n/a n/a
United States Revenue Growth +12.48% +59.07% +18.18% n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 12.99M 12.80M 14.11M 11.43M 11.04M 14.34M 14.98M 14.41M 15.23M 15.44M 15.24M 17.03M 13.43M 11.84M 10.77M 11.59M 11.06M 10.88M 12.48M 11.55M 12.14M 12.10M 11.92M 9.27M 7.81M 5.73M 2.28M 2.47M 2.57M 2.62M 2.43M 2.90M 3.29M 2.66M 2.35M 2.04M 1.97M 2.41M 2.04M
Selling, General, and Administrative Revenue Growth +1.52% -9.26% +23.39% +3.61% -23.07% -4.24% +3.94% -5.37% -1.37% +1.31% -10.49% +26.75% +13.43% +9.92% -7.02% +4.72% +1.69% -12.85% +8.11% -4.90% +0.36% +1.49% +28.63% +18.71% +36.20% +151.29% -7.73% -3.89% -1.98% +8.16% -16.34% -11.72% +23.68% +13.21% +14.83% +3.81% -18.37% +18.13% n/a
Research and Development Revenue 29.54M 29.82M 30.14M 17.95M 17.36M 15.73M 13.62M 15.54M 11.16M 12.99M 9.95M 8.92M 8.50M 5.61M 5.48M 5.21M 4.09M 3.28M 4.85M 4.13M 3.48M 3.96M 3.80M 4.18M 6.23M 4.76M 3.33M 4.27M 3.82M 4.21M 3.32M 3.17M 4.18M 4.10M 3.07M 3.72M 3.48M 3.20M 3.34M
Research and Development Revenue Growth -0.94% -1.05% +67.90% +3.39% +10.38% +15.51% -12.38% +39.25% -14.09% +30.64% +11.52% +4.94% +51.61% +2.30% +5.26% +27.26% +24.85% -32.50% +17.45% +18.60% -11.91% +4.16% -9.14% -32.95% +30.81% +43.31% -22.11% +11.78% -9.35% +26.74% +5.02% -24.25% +1.80% +33.51% -17.39% +6.86% +8.88% -4.22% n/a
Sales and Marketing Revenue 24.00K 50.00K 6.00K 185.00K 479.00K 5.29M 5.74M 5.92M 6.02M 6.88M 6.69M 7.81M 7.37M 6.66M 5.66M 5.81M 5.27M 6.09M 8.13M 7.40M 7.78M 7.28M 7.31M 4.53M 3.65M 1.51M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales and Marketing Revenue Growth -52.00% +733.33% -96.76% -61.38% -90.94% -7.83% -3.01% -1.68% -12.60% +2.84% -14.31% +5.93% +10.74% +17.67% -2.60% +10.27% -13.47% -25.06% +9.81% -4.87% +6.78% -0.37% +61.46% +24.19% +141.14% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a